HAMP and metabolic dysfunction-associated steatotic liver disease: Although hepcidin has long been known to be linked with insulin-resistant states, including type 2 diabetes mellitus, the Metabolic Syndrome (MetS) and obesity [11,38], those studies that have examined the relationship between circulating hepcidin levels and the presence or severity of NAFLD have reported conflicting data.